Australia markets closed

Monopar Therapeutics Inc. (MNPR)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
0.6582+0.0302 (+4.81%)
At close: 04:00PM EDT
0.6790 +0.02 (+3.16%)
After hours: 05:56PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
0
0
0
0
0
Operating expenses
Research development
5,600
5,600
7,592
6,493
4,065
Selling general and administrative
3,231
3,231
2,945
2,634
2,444
Total operating expenses
8,831
8,831
10,537
9,127
6,509
Operating income or loss
-8,831
-8,831
-10,537
-9,127
-6,509
Total other income/expenses net
-
-
-
-
122.4
Income before tax
-8,402
-8,402
-10,516
-9,103
-6,305
Income from continuing operations
-8,402
-8,402
-10,516
-9,103
-6,305
Net income
-8,402
-8,402
-10,516
-9,103
-6,305
Net income available to common shareholders
-8,402
-8,402
-10,516
-9,103
-6,305
Basic EPS
-0.72
-0.61
-0.83
-0.73
-0.58
Diluted EPS
-0.72
-0.61
-0.83
-0.73
-0.58
Basic average shares
13,384
13,824
12,718
12,471
10,958
Diluted average shares
13,384
13,824
12,718
12,471
10,958